Start your day off right with five things you need to know this morning.
Five things you need to know
GameStop stock is back on the up. Shares in the beleaguered company more than doubled on Wednesday afternoon. There is much speculation about whether the surge could be indicative of an impending replay of last month's stock price explosion caused by retail traders doing battle with hedge funds.
GameStop's stock price shot up by 90% following news that Jim Bell, the retailer's chief financial officer, is resigning. https://t.co/cZ29Fhnqlv— CNET (@CNET) February 24, 2021
Popular 1990s US sitcom Frasier is being revived, according to the show's star Kelsey Grammer. He said he was "gleefully" anticipating the "continuing journey" of lead character Dr. Frasier Crane. No details have been released, so it remains to be seen how a show about two wealthy brothers living in Seattle whose main concerns in life are fine dining and high culture can possibly be translated into the chaotic 2020s.
The People's Republic of China has denied that it forced US diplomats to undergo anal swab tests to see if they had COVID-19. The claim has appeared in American media. The US State Department said it had "never agreed" to anal testing.
The Chinese government has promised to stop using anal swabs on American diplomats to test for COVID-19, U.S. officials say. https://t.co/XKcPH0R8Op— VICE News (@VICENews) February 25, 2021
Australia's House of Representatives has passed a law aimed at making dominant US tech companies pay for news stories that appear on their platforms. Facebook and Google had both furiously opposed the law, with Facebook going as far as banning news for its Australia users in protest.
Australia has passed a new law that will force tech companies to pay publishers for news content, setting the stage for potential, similar action in other countries https://t.co/mLurp6hjFT— CNN Breaking News (@cnnbrk) February 25, 2021
The single-dose Johnson & Johnson COVID-19 vaccine has been deemed safe and effective by US regulators. It means the new shot could be authorized for use in the US in the coming days. Canada is among the countries to have ordered doses of the vaccine, though it has yet to be approved here.
Johnson & Johnson's single-shot Covid-19 vaccine is safe and effective, according to FDA analysis, a step toward possible authorization of a third shot in the U.S. https://t.co/aeyzZVNjXu— The Wall Street Journal (@WSJ) February 24, 2021